Susan G. Komen reports that it funds breast cancer research, provides direct assistance for those with breast cancer, and advocates for federal and state funding for breast cancer research, screening, and Medicaid eligibility expansion for breast cancer treatments. The organization states that direct assistance for patients includes: patient navigation, screening, diagnosis, treatment, education, health systems improvement, and psychosocial support programs. Susan G. Koman reports that programs operate in more than 30 countries. In 2018, the organization states that it funded 240 active research grants, with 62 of those being new grants. In addition, the organization reports that it funded screenings for 212,430 individuals, performed diagnostic testing for 41,610 individuals, provided treatment assistance to 32,850 individuals, and received 12, 775 calls to its Komen Breast Care Helpline. Some ($36,236,138 or 24%) of Susan G. Komen's programs are conducted in conjunction with informational materials that include fundraising appeals.
For the year ended March 31, 2018, Susan G. Komen's program expenses were:
| Public health education |
$93,691,227 |
| Research |
$32,295,812 |
| Treatment services |
$16,000,031 |
| Health screening services |
$11,398,188 |
| Total Program Expenses: |
$153,385,258 |
-
Chief Executive
Paula Schneider, President and Chief Executive Officer
-
Compensation*
$559,106
-
Chair of the Board
Peter Brundage
-
Chair's Profession / Business Affiliation
Retired, Managing Director, Investment Banking Division, Goldman Sachs
-
Board Size
14
-
Paid Staff Size
586
*2018 compensation, as reported by the organization, includes annual salary and, if applicable, benefit plans, expense accounts, and other allowances.
Method(s) Used:
Direct mail appeals, Grant proposals, Internet, Invitations to fund raising events, Planned giving arrangements, Print advertisements (newspapers, magazines, etc.), Telephone appeals, Radio, Cause- related marketing (affinity credit cards, consumer product sales, etc.), Television
Susan G. Komen incurred joint costs of $63,456,805 for informational materials and activities that included fund raising materials. Of those costs $36,236,138 was allocated to program expenses, $25,781,826 was allocated to fundraising expenses, and $1,438,841 was allocated to administrative expenses.
Fundraising costs were 17% of related contributions. (Related contributions, which totaled $175,967,131 are donations received as a result of fundraising activities.)
This organization is tax-exempt under section 501(c) (3) of the Internal Revenue Code.It is eligible to receive contributions deductible as charitable donations for federal income tax purposes.
The following information is based on Susan G. Komen's audited financial statements - consolidated for the year ended March 31, 2018.
| Source of Funds |
| Contributions, net |
$119,579,836 |
| In-kind contributions |
$56,387,295 |
| Realized and unrealized gains on investments |
$8,458,952 |
| Interest and dividends |
$5,836,650 |
| Other revenue |
$525,310 |
| Total Income |
$190,788,043 |
- Programs: 78%
- Fundraising: 14%
- Administrative: 8%
| Total Income |
$190,788,043 |
| Program expenses |
$153,385,258 |
| Fundraising expenses |
$29,098,200 |
| Administrative expenses |
$16,132,610 |
| Other expenses |
$0 |
| Total expenses: |
$198,616,068 |
| Income in Excess of Expenses |
$-7,828,025 |
| Beginning Net Assets |
$181,728,187 |
| Other Changes In Net Assets |
$0 |
| Ending Net Assets |
$173,900,162 |
| Total Liabilities |
$101,371,775 |
| Total Assets |
$275,271,937 |
Note: According to Susan G. Komen's audited financial statements - consolidated - for the year ended March 31, 2018, the organization received $56,387,295 in contributed goods and services including advertising ($46,483,502), occupancy and office expenses ($3,345,488), event production costs and support ($2,233,379), service fees and other expenses ($1,252,880), professional services ($1,206,461), travel expenses ($1,074,288), equipment rental ($752,778), miscellaneous ($20,280), and depreciation ($18,239).